Skip to content

TANG KEVIN

Follow

13F filer, CIK 1178579, SAN DIEGO, CA

TANG KEVIN filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-11-16.

Accepted , ingested 13F-NT 0001214659-26-014411

This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.

Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Part of the filer group TANG CAPITAL MANAGEMENT LLC

  • TANG CAPITAL MANAGEMENT LLC
  • TANG CAPITAL PARTNERS III, INC
  • TANG CAPITAL PARTNERS INTERNATIONAL, LP
  • TANG CAPITAL PARTNERS IV, INC
  • TANG CAPITAL PARTNERS, LP
How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • BOLD BOUNDLESS BIO INC: Form 4 bought 39,920 shares on 2026-11-20, 0001178579-26-000026Timeline
    Accepted , ingested
  • BOLD BOUNDLESS BIO INC: Form 4 bought 41,461 shares on 2026-11-19, 0001178579-26-000026Timeline
    Accepted , ingested
  • BOLD BOUNDLESS BIO INC: Form 4 bought 22,231 shares on 2026-11-18, 0001178579-26-000026Timeline
    Accepted , ingested
  • ARDX ARDELYX INC: 13G 14,336,247 shares, 5.7% of the class, 13G filed 2026-11-17, 0001214659-26-014519Timeline
    Accepted , ingested
  • INO INOVIO PHARMACEUTICALS INC: 13G 17,978,200 shares, 9.99% of the class, 13G filed 2026-11-16, 0001214659-26-014444Timeline
    Accepted , ingested
  • EYPT EYEPOINT INC: 13G 8,250,200 shares, 9.6% of the class, 13G filed 2026-10-27, 0001214659-26-013297Timeline
    Accepted , ingested
  • SKYE SKYE BIOSCIENCE INC: 13G 263,560 shares, 6% of the class, 13G filed 2026-10-14, 0001214659-26-012924Timeline
    Accepted , ingested
  • AVIR ATEA PHARMACEUTICALS INC: 13G 4,814,700 shares, 6% of the class, 13G filed 2026-10-06, 0001214659-26-012604Timeline
    Accepted , ingested

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-NT 0001214659-26-014411 notice2026-11-16